Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

January 31, 2014

Conditions
Healthy
Interventions
DRUG

HCP1104 / Mulex Tab. and Airtal Tab.

HCP1104 / Eperisone plus Aceclofenac

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01869985 - Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers | Biotech Hunter | Biotech Hunter